The frequency of clinical and subclinical hypothyroidism in transfusion dependent thalassemia patients in Slemani city /Iraq

Dezheen Jamal Mohammed  Rashid; Kawa Muhamad  Ameen; Nawsherwan Sadiq  Mohammed

doi:10.56056/amj.2024.265

Authors

Dezheen Jamal Mohammed Rashid MBChB, KHCMS Candidate/ Clinical Hematology. Hiwa Cancer hospital, Slemani, Kurdistan Region,Iraq
Kawa Muhamad Ameen MBChB, FRCP, PhD Assistant professor of clinical hematology , Department of Medicine, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region, Iraq.
Nawsherwan Sadiq Mohammed MBChB, FIBMS-path, Consultant hematopathologist Department of Pathology, Nanakali hospital, Erbil, Kurdistan Region, Iraq

DOI:

https://doi.org/10.56056/amj.2024.265

Keywords:

Hypothyroidism, Thyroid Stimulating Hormone (TSH), Transfusion Dependent Thalassemia (TDT), Serum Free Thyroxin (FT4)

Abstract

Background and objective: Thyroid disorders caused by blood transfusion in thalassemia patients could affect human health and growth, this study was conducted to determine the frequency of clinical and subclinical hypothyroidism in blood transfusion-dependent thalassemia patients in the city of Slemani, Kurdistan Region, Iraq.

Methods: The current study is a retrospective cross-sectional study (comparative analysis) conducted in Slemani center for thalassemia patients and congenital blood, between December 2021 and July 2022. Participants included l07 thalassemia patients with medical records the sampling method was a convenience method. The data was collected through the review of patients' files and blood tests, including( thyroid hormones, hemoglobin level, serum ferritin level), with a questionnaire that was completed through an interview with the patients.

Results: The results of thyroid function tests have shown that 21/107 pateints (19.6%) have hypothyroidism, 6 patients have overt hypothyroidism, and 15 patients have subclinical showed that 23/107 patients and 4/107 patients had hight and low levels,respectively, and there was statistically a significant difference in the average Thyroid stimulating hormone and serum thyroxin levels in two groups of hypothyroid and euthyroid patients and mean ferritine serum level between these two groups was 2166.7±2174.8 and 2068.37±1919.97 respictively ,which was not a statistically significant difference .

Conclusion: Considering the high prevalence of hypothyroidism in thalassemia patients, measuring Thyroid stimulating hormone and thyroxin can be very important and vital in the initial screenings,effective treatment and follow-up of patients.

Downloads

Download data is not yet available.

References

Cao A., Galanello R. Beta-thalassemia. Genet Med. 2010;12(2): 61-76.

Needs T, Gonzalez-Mosquera LF, Lynch DT. Beta Thalassemia, in StatPearls. StatPearls Publishing LLC.: Treasure Island (FL). 2022,

Munice JR H, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009 ;80(4):339-44.

Islam KA, Azam MS, Mahzabin N, Khan R, Shah MA, Aziz MA. Frequency of Hypothyroidism in Transfusion Dependent Thalassaemia Patients at a Tertiary Care Hospital. Haematology J. Bangladesh. 2020;4(1):16-8.

Sanctis VD, Elsedfy H, Soliman AT. et al. Endocrine profile of ?-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center. Indian J Endocrinol Metab. 2016; 20(4):451-9.

Sanctis VD, Soliman AT, Yassin MA, et al. Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment. Acta Biomed.2018; 89(2-s):6-15.

Farmaki K., Tzoumari I., Pappa C., Chouliaras G., Berdoukaset V. Normalization of total body iron load with intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol. 2010; 148(3): 466-75.

Al-Agha AE., Bawahab NS., Nagadi SA., Alghamdi SA., Felemban DA., Milyani AA. Endocrinopathies complicating transfusion-dependent hemoglobinopathy. Saudi Med J. 2020; 41(2):138–43.

Belhoul KM., Bakir ML., Saned MS., Kadhim AM., Musallam KM., Taher AT. Serum ferritin levels and endocrinopathy in medically treated patients with ? thalassemia major. Ann Hematol.2012;91(7):1107-14.

Shalitin S., Carmi D., Weintrob N.et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol. 2005; 74(2):93-100.

Inati A., Noureldine MA, Mansour A, Abbas HA. Endocrine and Bone Complications in ?-Thalassemia Intermedia: Current Understanding and Treatment. Biomed Res Int. 2015; 2015: 813098.

Lubis DA., Yunir EM. Endocrinopathies in thalassemia major patient. IOP Conf. Ser.: Earth Environ. Sci. 2018; 125:012174.

Rasheed NE, Ahmed SA. Effect of ß-Thalassemia on some Biochemical Parameters. Middle East J. Fam. Med. 2009;7(2): 30-51.

Soliman AT, Al Yafei F, Al-Naimi L. et al. Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years. Indian J. Endo. Metab. 2013; 17(6):1090-5.

Yassouf MY, Alquobaili F, Kabalan Y, Mukhalalaty Y. Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with ?-Thalassemia Major in Syria. Hemoglobin. 2019; 43(3): 218-221.

Mettananda S, Pathiraja H, Peiris R. et al. Blood transfusion therapy for ??thalassemia major and hemoglobin E ??thalassemia: Adequacy, trends, and determinants in Sri Lanka. Pediatr. Blood Cancer. 2019;66(5): e27643.

Batool T, Irim S, Naeem MM, et al. Hypothyroidism in Children with ?-Thalassemia at a Tertiary Hospital of South Punjab, Pakistan. Pak J Med Sci. 2022; 16(07):266-8.

Haghpanah S, Bensenjan MH, Sayadi M, et al. The prevalence of Hypothyroidism among patients with ?-thalassemia: a systematic review and meta-analysis of cross-sectional studies. Hemoglobin. 2021; 45(5):275-286.

Imran A, Wani G, Sing K. Assessment of thyroid profile in children with thalassemia and its correlation with serum ferritin level. Int. J. Med. Health Res. 2018; 4(10):1368.

Hamdy M, Draz IH, El Sayed IT, Ayad AA, Salemd MR. Assessment of Quality of Life among Beta-Thalassemia Major Patients Attending the Hematology Outpatient Clinics at Cairo University Hospital. Open Access Maced J Med Sci. 2021; 9(E): 156-60.

Kadhum SJ. The prevalence of Hypothyroidism among patients with beta-thalassemia major, Western Iraq. Iraqi Postgrad. Med. J.2018; 17(2):170-5.

Anafje M, Jaseb K, Yousefi H. Association Between Serum Ferritin Level and Gene Mutations in Patients with Thalassemia Major and Intermediate. Jundishapur J. Chronic Dis. Care. 2021; 10(1): e110304.

Baul, S, Dolai TK, Sahana PK, et al. Does Thyroid dysfunction correlates with iron overload in E? thalassemia patients? A study from a tertiary care thalassemia center in India. Archives Med. & Health Sci. 2019; 7(2): 206-11.

Iqbal J, Khan KA, Khan ZA, Salman S, Riaz A., Hassan S. Frequency of Hypothyroidism in ?eta Thalassemia Patients. Pakistan J. Med. & Health Sci. 2022; 16(7): 52-3.

Vincenzo DS, Ashraf TS, Duran C, et al. An ICET-A survey on occult and emerging endocrine complications in patients with ?-thalassemia major: Conclusions and recommendations. Acta Biomed.: Atenei Parmensis. 2018; 89(4): 481-9.

Sharmin T, Mollah AH, Morshed AA, Chowdhury MK. Thyroid Status in Children with Transfusion Dependent Hb-E ?-Thalassaemia. Mymensingh Med J..2018;27(2): 348-57.

Kanbour I, Chandra P, Soliman A et al. Severe liver iron concentrations (LIC) in 24 patients with ?-thalassemia major: correlations with the serum ferritin, liver enzymes and endocrine complications. Mediterr. J. Hematol Infect. Dis..2018;10(1): e2018062.